Quesada VAJ, Suarez QA, Álvares AA

Language: Spanish
References: 20
Page:
PDF size: 358.01 Kb.

ABSTRACT

Introduction: migraine is a common and disabling disease, however, there is little research on the predictive factors of disability.
Objective: to create an explanatory theoretical model of the dynamic interrelation between the factors associated with migraine disability and, in turn, the individual relationship of each of these factors with disability.
Methods: to carry out this research, the rationalist-deductive approach was assumed as an epistemological position, and the hypothetical-deductive and systemic-structural methods were used to achieve it.
Results: revealing theoretical elements of the complex relationship that exists between disability due to migraine and its determining factors were exposed.
Conclusions: an explanatory model of the dynamic interrelation between the different factors with independent influence on migraine disability and, in turn, the individual relationship of each of these factors with disability was created.

REFERENCES

1. Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z. Lifting The Burden: the Global Campaign against Headache. Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020; 21(1):137-40.

2. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1) 1-211.

3. Aurora SK, Brin MF. Chronic migraine: an update on physiology, imaging, and the mechanism of action of two available pharmacologic therapies. Headache. 2017; 57(1):109-25.

4. Láinez Andrés JM, Mederer Hengstl S, Monzón Monguillod MJ, Soler González R. Epidemiología de las cefaleas. En: Santos Lasaosa S, Pozo Rosich P, eds. Manual de Práctica Clínica en Cefaleas. Recomendaciones diagnóstico-terapéuticas de la Sociedad Española de Neurología en 2020. [Internet]. Madrid: Luzán 5 Health Consulting, S.A; 2020. p. 15-44 [citado 20/01/2022]. Disponible en: https://www.sen.es/pdf/2020/ManualCefaleas2020.pdf4. .

5. Quesada Vázquez AJ, Contreras Maure LJ, Pérez Joa AS, Mendoza Acosta O, Álvarez Aliaga A, Frómeta Guerra A. Prevalencia y características clínico epidemiológicas de la migraña en Bayamo. Multimed. 2017; 21(4):414-29.

6. Quesada Vázquez AJ, Álvarez Aliaga A, González Aguilera JC. Factores de riesgo de discapacidad moderada a grave por migraña. Multimed. 2017; 21(5): 613-26.

7. Quesada Vázquez AJ, Álvarez Aliaga A, González Aguilera JC. Índice predictivo para la discapacidad moderada a grave por migraña. MEDISAN. 2018; 22(8):984-96.

8. Aich A, Afrin LB, Gupta K. Mast cell-mediated mechanisms of nociception. Int J Mol Sci. 2015; 16:29069-92.

9. De Tommaso M, Vecchio E, Quitadamo SG, Coppola G, Di Renzo A, Parisi V, et al. Pain-Related Brain Connectivity Changes in Migraine: A Narrative Review and Proof of Concept about Possible Novel Treatments Interference. Brain Sci. 2021; 11(2):234-54.

10. Edvinsson L, Tajti J, Szalárdy L, Vécsei L. PACAP and its role in primary headaches. J Headache Pain. 2018; 19:21-27.

11. Younis S, Hougaard A, Noseda R, Ashina M. Current understanding of thalamic structure and function in migraine. Cephalalgia. 2019 ; 39(13): 1675-82.

12. Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltrán E, et al. Blocking CGRP in migraine patients - a review of pros and cons. J Headache Pain. 2017; 18(1):96-104.

13. Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, et al. Comorbid and co-occurring conditions in migraine and associatedrisk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) Study. J Headache Pain. 2020; 21(1):23-38.

14. Takahashi TT, Ornello R, Quatrosi G, Torrente A, Albanese M, Vigneri S, et al. Medication overuse and drug addiction: a narrative review from addiction perspective. J Headache Pain. 2021; 22:32-42.

15. Pinheiro Campos AC, Antunes GF, Matsumoto M, Lima Pagano R, Ruiz Martínez RC. Neuroinflammation, pain and depression: an overview of the main findings. Front. Psychol. 2020; 11:1825-54.

16. Whibley D, AlKandari N, Kristensen K, Barnish M, Rzewuska M, Druce KL, et al. Sleep and Pain: A Systematic Review of Studies of Mediation. Clin J Pain. 2019; 35(6):544-58.

17. Fang H, Tu S, Sheng J, Shao A. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med. 2019; 23(4):2324-32.

18. Kalmbach DA, Anderson JR, Drake CL. The impact of stress on sleep: Pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders. J Sleep Res. 2018; 27(6): e12710.

19. Cámara MS, Martín Bujanda M, Mendioroz Iriarte M. Modificaciones epigenéticas en las cefaleas. Neurología. 2021; 36(2021):369-76.

20. Ashina M, Moller Hansen J, Phu Do T, Melo Carrillo A, Burstein R, Moskowitz MA. Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol. 2019; 18(8):795-804.